Genomic copy-number alterations of MYC and FHIT genes are associated with survival in esophageal squamous-cell carcinoma

Cancer Science

Volumn 103, Issue 8, 2012, Pages 1558-1566

  Miyawaki, Yutaka ^a,b   Kawachi, Hiroshi ^b   Ooi, Akishi ^c   Eishi, Yoshinobu ^b   Kawano, Tatsuyuki ^b   Inazawa, Johji ^a,b   Imoto, Issei ^d  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FRAGILE HISTIDINE TRIAD PROTEIN; MYC PROTEIN;

ADULT; AGED; ARTICLE; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CHROMOSOME ANALYSIS; COHORT ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER VARIATION; DISEASE FREE SURVIVAL; ESOPHAGUS CARCINOMA; FEMALE; GENETIC ASSOCIATION; GENOMICS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MUTATION; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; SQUAMOUS CELL CARCINOMA;

ACID ANHYDRIDE HYDROLASES; CARCINOMA, SQUAMOUS CELL; CHROMOSOMAL INSTABILITY; COMPARATIVE GENOMIC HYBRIDIZATION; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; FOLLOW-UP STUDIES; GENES, MYC; HUMANS; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROPORTIONAL HAZARDS MODELS; REAL-TIME POLYMERASE CHAIN REACTION; SURVIVAL ANALYSIS;

EID: 84864296088     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2012.02329.x     Document Type: Article

References (31)

1. Shahbaz Sarwar CM, Luketich JD, Landreneau RJ, Abbas G. Esophageal cancer: an update. Int J Surg 2010; 8: 417-22.
2. Solomon E, Borrow J, Goddard AD. Chromosome aberrations and cancer. Science 1991; 254: 1153-60.
3. Yen CC, Chen YJ, Chen JT et al. Comparative genomic hybridization of esophageal squamous cell carcinoma: correlations between chromosomal aberrations and disease progression/prognosis. Cancer 2001; 92: 2769-77.
4. Ueno T, Tangoku A, Yoshino S et al. Gain of 5p15 detected by comparative genomic hybridization as an independent marker of poor prognosis in patients with esophageal squamous cell carcinoma. Clin Cancer Res 2002; 8: 526-33.
5. Kwong D, Lam A, Guan X et al. Chromosomal aberrations in esophageal squamous cell carcinoma among Chinese: gain of 12p predicts poor prognosis after surgery. Hum Pathol 2004; 35: 309-16.
6. Carneiro A, Isinger A, Karlsson A et al. Prognostic impact of array-based genomic profiles in esophageal squamous cell cancer. BMC Cancer 2008; 8: 98.
7. Shi ZZ, Liang JW, Zhan T et al. Genomic alterations with impact on survival in esophageal squamous cell carcinoma identified by array comparative genomic hybridization. Genes Chromosom Cancer 2011; 50: 518-26.
8. Sobin LH, Hermanek P, Hutter RVP. International Union Against Cancer (UICC): TNM Classification of Malignant Tumors, 6th edn. New York: Wiley, 2002.
9. Japan Esophageal Society. Japanese Classification of Esophageal Cancer, 10th edn, part I. Esophagus 2009; 6: 1-25.
10. Sonoda I, Imoto I, Inoue J et al. Frequent silencing of low density lipoprotein receptor-related protein 1B (LRP1B) expression by genetic and epigenetic mechanisms in esophageal squamous cell carcinoma. Cancer Res 2004; 64: 3741-7.
11. Inazawa J, Inoue J, Imoto I. Comparative genomic hybridization (CGH)-arrays pave the way for identification of novel cancer-related genes. Cancer Sci 2004; 95: 559-63.
12. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998; 396: 643-9.
13. Masuda A, Takahashi T. Chromosome instability in human lung cancers: possible underlying mechanisms and potential consequences in the pathogenesis. Oncogene 2002; 21: 6884-97.
14. Iwakawa R, Kohno T, Kato M et al. MYC amplification as a prognostic marker of early-stage lung adenocarcinoma identified by whole genome copy number analysis. Clin Cancer Res 2011; 17: 1481-9.
15. Roder JD, Busch R, Stein HJ, Fink U, Siewert JR. Ratio of invaded to removed lymph node are predictors of survival in squamous cell carcinoma of the esophagus. Br J Surg 1994; 81: 410-3.
16. Ohtsu A. Chemoradiotherapy for esophageal cancer: current status and perspectives. Int J Clin Oncol 2004; 9: 444-50.
17. Futreal PA, Coin L, Marshall M et al. A census of human cancer genes. Nat Rev Cancer 2004; 4: 177-83.
18. Santarius T, Shipley J, Brewer D, Stratton MR, Cooper CS. A census of amplified and overexpressed human cancer genes. Nat Rev Cancer 2010; 10: 59-64.
19. Beroukhim R, Mermel CH, Porter D et al. The landscape of somatic copy-number alteration across human cancers. Nature 2010; 463: 899-905.
20. Komatsu S, Imoto I, Tsuda H et al. Overexpression of SMYD2 relates to tumor cell proliferation and malignant outcome of esophageal squamous cell carcinoma. Carcinogenesis 2009; 30: 1139-46.
21. Begum A, Imoto I, Kozaki K et al. Identification of PAK4 as a putative target gene for amplification within 19q13.12-q13.2 in oral squamous-cell carcinoma. Cancer Sci 2009; 100: 1908-16.
22. Mori M, Mimori K, Shiraishi T et al. Altered expression of Fhit in carcinoma and precarcinomatous lesions of the esophagus. Cancer Res 2000; 60: 1177-82.
23. Kuroki T, Trapasso F, Yendamuri S et al. Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma. Cancer Res 2003; 63: 3724-8.
24. Nie Y, Liao J, Zhao X, Yang G, Wang L, Yang C. Detection of multiple gene hypermethylation in the development of esophageal squamous cell carcinoma. Carcinogenesis 2002; 23: 1713-20.
25. Guo XQ, Wang SJ, Zhang LW, Wang XL, Zhang JH, Guo W. DNA methylation and loss of protein expression in esophageal squamous cell carcinogenesis of high-risk area. J Exp Clin Cancer Res 2007; 26: 587-94.
26. Knudson AG. Hereditary cancer, oncogenes, and antioncogenes. Cancer Res 1985; 45: 1437-43.
27. Shimada Y, Sato F, Watanabe G et al. Loss of fragile histidine triad gene expression is associated with progression of esophageal squamous cell carcinoma, but not with the patient's prognosis and smoking history. Cancer 2000; 89: 5-11.
28. Pelengaris S, Rudolph B, Littlewood T. Action of myc in vivo-Proliferation and apoptosis. Curr Opin Genet Dev 2000; 10: 100-5.
29. Nesbit CE, Tersak JM, Prochownik EV. MYC oncogenes and human neoplastic disease. Oncogene 1999; 18: 3004-16.
30. Bitzer M, Stahl M, Arjumand J et al. C-myc gene amplification in different stages of oesophageal squamous cell carcinoma: prognostic value in relation to treatment modality. Anticancer Res 2003; 23: 1489-93.
31. Huang XP, Rong TH, Wang JY et al. Negative implication of C-MYC as an amplification target in esophageal cancer. Cancer Genet Cytogenet 2006; 165: 20-4.